Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications

Class:IdLiteratureReference:8955171
_displayNameThe role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications
_timestamp2017-01-10 21:26:40
author[Person:8955174] Sang, Youzhou
[Person:8955173] Yan, Fan
[Person:8955175] Ren, Xiubao
created[InstanceEdit:8955172] Rothfels, Karen, 2017-01-10
journalOncotarget
pages42590-602
pubMedIdentifier26460955
titleThe role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications
volume6
year2015
(literatureReference)[Reaction:8952638] AcM-UBE2M transfers NEDD8 to CRL4 E3 ubiquitin ligase complex [Homo sapiens]
[Reaction:8952639] NEDD8:AcM-UBE2M binds CRL4 E3 ubiquitin ligase complex [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications (8955171)